RU2016123849A - A method for the treatment of catarrhal mastitis of lactating cows - Google Patents
A method for the treatment of catarrhal mastitis of lactating cows Download PDFInfo
- Publication number
- RU2016123849A RU2016123849A RU2016123849A RU2016123849A RU2016123849A RU 2016123849 A RU2016123849 A RU 2016123849A RU 2016123849 A RU2016123849 A RU 2016123849A RU 2016123849 A RU2016123849 A RU 2016123849A RU 2016123849 A RU2016123849 A RU 2016123849A
- Authority
- RU
- Russia
- Prior art keywords
- cows
- novocaine
- treatment
- therapeutic agent
- lactating cows
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 6
- 241000283690 Bos taurus Species 0.000 title claims 4
- 208000004396 mastitis Diseases 0.000 title claims 2
- 239000003814 drug Substances 0.000 claims 4
- 229940053973 novocaine Drugs 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- UWGHBOXQOJIGDX-QESCWDNQSA-M potassium;n,n'-dibenzylethane-1,2-diamine;2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabic Chemical compound [K+].CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.C=1C=CC=CC=1CNCCNCC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 UWGHBOXQOJIGDX-QESCWDNQSA-M 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016123849A RU2016123849A (en) | 2016-06-15 | 2016-06-15 | A method for the treatment of catarrhal mastitis of lactating cows |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016123849A RU2016123849A (en) | 2016-06-15 | 2016-06-15 | A method for the treatment of catarrhal mastitis of lactating cows |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2016123849A true RU2016123849A (en) | 2017-12-20 |
Family
ID=60718218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016123849A RU2016123849A (en) | 2016-06-15 | 2016-06-15 | A method for the treatment of catarrhal mastitis of lactating cows |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2016123849A (en) |
-
2016
- 2016-06-15 RU RU2016123849A patent/RU2016123849A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX393855B (en) | COMBINATION THERAPY INCLUDING A RAF INHIBITOR AND TRAMETINIB | |
| RU2013121788A (en) | HIV REPLICATION INHIBITORS | |
| EA201101518A1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY | |
| RU2017105353A (en) | COMPOUNDS | |
| BR112015018252A2 (en) | stable fixed-dose aqueous pharmaceutical composition for nasal administration to a human, stable fixed-dose aqueous pharmaceutical composition for nasal administration for a human, stable suspension suitable for nasal administration to a human, method for treating rhinitis in a human human in need thereof, use of the pharmaceutical composition for nasal administration, method for releasing a pharmaceutical composition and kit | |
| RU2015134581A (en) | NITROXIL DONORS WITH IMPROVED THERAPEUTIC INDEX | |
| JP2017533972A5 (en) | ||
| RU2018125622A (en) | METHOD OF APPLICATION OF CARRYMICIN AGAINST RESISTANCE OF INFECTION PROVIDED BY MYCOBACTERIA TUBERCULOSIS | |
| RU2018106533A (en) | NEW TRIPSIN ISOFORM AND THEIR APPLICATION | |
| RU2017128296A (en) | Composition for the treatment of infertility | |
| PH12019502651A1 (en) | Use of vibegron to treat overactive bladder | |
| RU2017112303A (en) | METHOD FOR USING THE COMBINATION OF A NEW HYDROXAMIC ACID DERIVATIVE AND ANTIBACTERIAL SUBSTANCE | |
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| BR112015027636A2 (en) | USE OF THE PHARMACEUTICAL COMPOSITION | |
| MX2015016750A (en) | Immunogenic composition for use in therapy. | |
| JOP20190019A1 (en) | Pharmaceutical Formula for Treatment of Growth Hormone Deficiency Contains Human Growth Hormone (hGH) Fusion Protein | |
| HRP20201187T1 (en) | TRIAZOLOPYRAZINONE DERIVATIVE USED AS AN INHIBITOR OF HUMAN PDE1 | |
| MX2015014939A (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias. | |
| HK1255114A1 (en) | Antifungal agent | |
| MY170991A (en) | Dosing regimens of celgosivir for the treatment of dengue | |
| PH12019502510A1 (en) | Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof | |
| RU2016123849A (en) | A method for the treatment of catarrhal mastitis of lactating cows | |
| AR101227A1 (en) | COMBINATIONS OF A N-TIAZOLIL-4-PHENOXIBENCENOSULFONAMIDE DERIVATIVE AND A PHARMACEUTICALLY ACTIVE AGENT SELECTED FROM GABAPENTINE AND PREGABALINE TO TREAT PAIN | |
| RU2008152691A (en) | METHOD FOR PREVENTION AND TREATMENT OF MASTITIS IN COWS | |
| RU2016145411A (en) | The combination of brexpiprazole and nalmefene, and its use for the treatment of the syndrome of chemical dependence |